News >

Cell-Free DNA Sequencing Could Help Early Detection of Lung Cancer

Brandon Scalea
Published: Thursday, Sep 27, 2018

Geoffrey R.
Oxnard, MD

Geoffrey R. Oxnard, MD
Early-stage lung cancers are detectable in cell-free DNA (cfDNA) using a genome-wide sequencing approach, according to findings of The Circulating Cancer Genome Atlas (CCGA) study.

The study enrolled 12,292 patients, of which 70% with cancer and 30% without. Two initial cohorts were created with a training set (1733 clinically evaluable samples, 127 positive for lung cancer) and a test set (n = 980 clinically evaluable samples, 47 positive for lung cancer).
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Experts Weigh-In on Emerging Immune Checkpoint Inhibitors and Combination Strategies for Advanced NSCLCNov 30, 20191.5
Burst CME™ – Cancer Summaries and Commentaries: Update from Toronto: Advances in the Treatment of Lung CancersNov 30, 20190.5
Publication Bottom Border
Border Publication